Photo: MD Anderson cancer center/Twitter
Jun 1, 2023, 02:37
Luspatercept: A Transformative Therapy for Transfusion-Dependent Myelodysplastic Syndromes
Luspatercept is a transformative therapy for patients with transfusion-dependent myelodysplastic syndromes (MDS). Esteemed oncologist, Dr. Guillermo Garcia-Manero, believes it has the potential to become the new standard of care for MDS patients. Luspatercept works by enhancing red blood cell formation, reducing the need for frequent blood transfusions. Its introduction offers renewed hope and the potential to improve outcomes and quality of life for individuals with MDS.